Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Vivien Hebert

Higher Frequency of Dipeptidyl Peptidase IV Inhibitor Intake in Bullous Pemphigoid Patients Than in the French General Population

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Linear IgA Bullous Dermatosis Treated With Rituximab

JAAD Case Reports
Dermatology
2019English

Related publications

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid

2019English

Dipeptidyl Peptidase-Iv Inhibitors, a Risk Factor for Bullous Pemphigoid. Retrospective Multicenter Case-Control Study in France and Switzerland

Journal of the American Academy of Dermatology
Dermatology
2018English

Oral Diabetes Medications Other Than Dipeptidyl Peptidase-4 Inhibitors Are Not Associated With Bullous Pemphigoid: A Finnish Nationwide Case Control Study

Journal of the American Academy of Dermatology
Dermatology
2018English

Distribution of Dipeptidyl Peptidase IV in Patients With Chronic Tonsillitis

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2008English

Wound Healing Process and Dipeptidyl Peptidase IV

Medicina fluminensis
2017English

General Anaesthesia of a Bullous Pemphigoid Patient

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1996English

DPP-4 Inhibitor-Associated Bullous Pemphigoid in a Hemodialysis Patient

Internal Medicine
Internal MedicineMedicine
2020English

Bullous Pemphigoid

2020English

Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy